ImmunityBio, Inc.IBRXNASDAQ
Loading
Capital Expenditure Over TimeExpanding
Percentile Rank67
Studio
Year-over-Year Change

Cash spent on acquiring or upgrading physical assets

Latest
$-3.07M
↑ 86% vs avg
Percentile
P67
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
$-21.27M
Historical baseline
PeriodValueYoY Change
TTM$-3.07M+55.4%
2024$-6.89M+77.5%
2023$-30.58M+60.9%
2022$-78.16M-132.9%
2021$-33.56M-1911.0%
2020$-1.67M+61.1%
2019$-4.29M+67.3%
2018$-13.10M+62.4%
2017$-34.81M-430.7%
2016$-6.56M-